🇺🇸 FDA
Patent

US 7922999

Administration of growth factors for the treatment of CNS disorders

granted A61KA61K33/242A61K33/244

Quick answer

US patent 7922999 (Administration of growth factors for the treatment of CNS disorders) held by The Regents of the University of California expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K33/242, A61K33/244, A61K38/18, A61K38/185